Prata Alexandre B, Drum Jéssica N, Melo Leonardo F, Araujo Estela R, Sartori Roberto
Department of Animal Science, Luiz de Queiroz College of Agriculture (ESALQ), University of São Paulo, Av. Pádua Dias, 11, Piracicaba, SP 13418-900, Brazil.
Department of Dairy Science, University of Wisconsin-Madison, 1675 Observatory Drive, Madison, WI 53706, USA.
Theriogenology. 2018 Apr 15;111:52-55. doi: 10.1016/j.theriogenology.2018.01.011. Epub 2018 Jan 31.
The aim of this study was to evaluate the effect of eCG or hCG on the final growth of the dominant follicle in Nelore (Bos indicus) cows submitted to fixed-time AI (FTAI). Eighty-four lactating cows with body condition score (BCS) of 2.9 (range 1-5) were used. At a random day of the estrous cycle (D0) cows received 2 mg estradiol benzoate and a reused intravaginal progesterone device (1.9 g). At D8, when the device was removed, 0.5 mg cloprostenol and 1 mg estradiol cypionate was given i.m., and cows were randomly assigned to receive on D8 one of the following treatments: Control (no treatment; n = 17), eCG (300 IU i.m.; n = 17), hCG 300 (300 IU i.m.; n = 18), hCG 200 IM (200 IU i.m.; n = 16) and hCG 200 SC (200 IU s.c.; n = 16). On the same day and 2 days later, cows were subjected to ovarian ultrasonography to evaluate the diameter of the largest follicle and to calculate follicular growth rate (D8 to D10). No differences were observed for the diameter of the largest follicle on D8 (P = 0.3) or D10 (P = 0.4) among treatments. However, the growth rate of the dominant follicle between D8 and D10 was greater for the groups eCG and hCG 300 and there were no differences between the other treatments (Control = 1.1 mm/day; eCG = 1.8 mm/day; hCG 300 = 1.8 mm/day; hCG 200 IM = 1.3 mm/day; hCG 200 SC = 1.3 mm/day; P = 0.02). In addition, more cows from the Group hCG 300 presented premature ovulation (44.4%) than cows from Control (5.8%), eCG (0%), or hCG 200 IM (12.5%), but did not differ from Group hCG 200 SC (18.7%). Regardless of treatment, the size of the largest follicle on D8 was different between cows that presented premature ovulation vs. cows that did not ovulate prematurely (11.3 mm vs. 9.9 mm, respectively; P = 0.01). Treatment with different hCG doses on D8 of a FTAI protocol failed to produce similar effects compared to eCG in terms of final follicular growth support and greater ovulatory follicle size. In addition, the groups hCG 300 and hCG 200 SC induced premature ovulation in a greater portion of cows. Thus, a single administration of hCG on D8 does not appear to be a reliable alternative to eCG treatment in FTAI protocols.
本研究的目的是评估孕马血清促性腺激素(eCG)或人绒毛膜促性腺激素(hCG)对接受定时人工授精(FTAI)的内洛尔(印度瘤牛)母牛优势卵泡最终生长的影响。使用了84头体况评分为2.9(范围1 - 5)的泌乳母牛。在发情周期的随机一天(D0),母牛接受2毫克苯甲酸雌二醇和一个重复使用的阴道孕酮装置(1.9克)。在D8,当取出装置时,肌肉注射0.5毫克氯前列醇和1毫克环丙孕酮,并且母牛被随机分配在D8接受以下处理之一:对照组(不处理;n = 17)、eCG(300国际单位肌肉注射;n = 17)、hCG 300(30百国际单位肌肉注射;n = 18)、hCG 200 IM(200国际单位肌肉注射;n = 16)和hCG 200 SC(200国际单位皮下注射;n = 16)。在同一天以及两天后,对母牛进行卵巢超声检查以评估最大卵泡的直径并计算卵泡生长速率(D8至D10)。各处理组之间在D8(P = 0.3)或D10(P = 0.4)时最大卵泡直径未观察到差异。然而,eCG组和hCG 300组在D8至D10期间优势卵泡的生长速率更大,其他处理组之间无差异(对照组 = 1.1毫米/天;eCG = 1.8毫米/天;hCG 300 = 1.8毫米/天;hCG 200 IM = 1.3毫米/天;hCG 200 SC = 1.3毫米/天;P = 0.02)。此外,hCG 300组出现过早排卵的母牛比例(44.4%)高于对照组(5.8%)、eCG组(0%)或hCG 200 IM组(12.5%),但与hCG 200 SC组(18.7%)无差异。无论处理如何,出现过早排卵的母牛与未过早排卵的母牛在D8时最大卵泡大小不同(分别为11.3毫米和9.9毫米;P = 0.01)。在FTAI方案的D8时,与eCG相比,使用不同剂量hCG处理在最终卵泡生长支持和更大排卵卵泡大小方面未能产生相似效果。此外,hCG 300组和hCG 200 SC组在更大比例的母牛中诱导了过早排卵。因此,在FTAI方案中,在D8单次注射hCG似乎不是eCG处理的可靠替代方法。